• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: PD

Treatment of motor symptoms of PD: MDS recommendations

April 11, 2012  

Neuropathy in PD attributed to vitamin B12 deficiency

February 22, 2012  

Dopamine agonists in PD: need to explain risks of problem gambling

February 8, 2012  

MCI in PD: Movement Disorder Society Task Force report

January 25, 2012  

No evidence that NSAIDs lower PD risk

October 5, 2011  

Inhaled apomorphine tested in severe PD

September 14, 2011  

Infection history may influence PD risk

September 14, 2011  

Predictors of dyskinesia: STRIDE-PD analysis

September 14, 2011  

Call for guidelines on managing PD patients in hospital

September 7, 2011  

PD progression, QOL impairments less in females

August 3, 2011  
Previous
2
3
4
5
6
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Treatment discontinuation in MS: the DOT-MS trial posted on May 5, 2025
  • AAN 2025 – report on fluid biomarkers in MS posted on April 22, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions